183 related articles for article (PubMed ID: 16009822)
1. Imaging of pelvic malignancies with in-line FDG PET-CT: case examples and common pitfalls of FDG PET.
Subhas N; Patel PV; Pannu HK; Jacene HA; Fishman EK; Wahl RL
Radiographics; 2005; 25(4):1031-43. PubMed ID: 16009822
[TBL] [Abstract][Full Text] [Related]
2. Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls.
De Gaetano AM; Calcagni ML; Rufini V; Valentini AL; Gui B; Giordano A; Bonomo L
Abdom Imaging; 2009 Nov; 34(6):696-711. PubMed ID: 18791682
[TBL] [Abstract][Full Text] [Related]
3. Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
De Gaetano AM; Rufini V; Castaldi P; Gatto AM; Filograna L; Giordano A; Bonomo L
Abdom Imaging; 2012 Dec; 37(6):983-1003. PubMed ID: 22527152
[TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma.
Okada M; Sato N; Ishii K; Matsumura K; Hosono M; Murakami T
Radiographics; 2010; 30(4):939-57. PubMed ID: 20631361
[TBL] [Abstract][Full Text] [Related]
5. Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies.
Agarwal KK; Roy SG; Kumar R
PET Clin; 2016 Jan; 11(1):39-46. PubMed ID: 26590442
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET/CT in the evaluation of anal carcinoma.
Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889
[TBL] [Abstract][Full Text] [Related]
7. Imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls.
De Gaetano AM; Calcagni ML; Rufini V; Valenza V; Giordano A; Bonomo L
Abdom Imaging; 2009; 34(3):391-402. PubMed ID: 18446399
[TBL] [Abstract][Full Text] [Related]
8. FDG PET/CT Pitfalls in Gynecologic and Genitourinary Oncologic Imaging.
Lakhani A; Khan SR; Bharwani N; Stewart V; Rockall AG; Khan S; Barwick TD
Radiographics; 2017; 37(2):577-594. PubMed ID: 28287942
[TBL] [Abstract][Full Text] [Related]
9. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.
Shammas A; Lim R; Charron M
Radiographics; 2009; 29(5):1467-86. PubMed ID: 19755606
[TBL] [Abstract][Full Text] [Related]
10. Bowel hot spots at PET-CT.
Prabhakar HB; Sahani DV; Fischman AJ; Mueller PR; Blake MA
Radiographics; 2007; 27(1):145-59. PubMed ID: 17235004
[TBL] [Abstract][Full Text] [Related]
11. Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake.
Blodgett TM; Fukui MB; Snyderman CH; Branstetter BF; McCook BM; Townsend DW; Meltzer CC
Radiographics; 2005; 25(4):897-912. PubMed ID: 16009814
[TBL] [Abstract][Full Text] [Related]
12. Clinical applications of positron emission tomography-computed tomography in oncology.
Kumar R; Halanaik D; Malhotra A
Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
[TBL] [Abstract][Full Text] [Related]
13. [18F-FDG PET/CT with retrograde filling of the urinary bladder in the assessment of malignant pelvic disease].
García Vicente AM; Núñez García A; Palomar Muñoz A; Pilkington Woll JP; Bellón Guardia ME; González García B; Soriano Castrejón A
Rev Esp Med Nucl; 2011; 30(2):71-6. PubMed ID: 21334772
[TBL] [Abstract][Full Text] [Related]
14. The Basic Principles of FDG-PET/CT Imaging.
Basu S; Hess S; Nielsen Braad PE; Olsen BB; Inglev S; Høilund-Carlsen PF
PET Clin; 2014 Oct; 9(4):355-70, v. PubMed ID: 26050942
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
16. FDG PET-CT of gynecologic cancers: pearls and pitfalls.
Prabhakar HB; Kraeft JJ; Schorge JO; Scott JA; Lee SI
Abdom Imaging; 2015 Oct; 40(7):2472-85. PubMed ID: 25680500
[TBL] [Abstract][Full Text] [Related]
17. FDG in Urologic Malignancies.
Høilund-Carlsen PF; Poulsen MH; Petersen H; Hess S; Lund L
PET Clin; 2014 Oct; 9(4):457-68, vi. PubMed ID: 26050947
[TBL] [Abstract][Full Text] [Related]
18. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography-computed tomography imaging for malignancies in women.
Viswanathan C; Bhosale PR; Shah SN; Vikram R
Radiol Clin North Am; 2013 Nov; 51(6):1111-25. PubMed ID: 24210447
[TBL] [Abstract][Full Text] [Related]
20. Physiologic uptake of 18F-FDG in transposed ovaries may mimic metastasis on 18F-FDG PET/CT imaging.
Davidson T; Komisar O; Korach J; Felder S; Apter S; Ben-Haim S; Perri T
Nucl Med Commun; 2018 Feb; 39(2):171-178. PubMed ID: 29215392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]